- Home
- EDIT vs LOGC Comparison
EDIT vs LOGC Comparison
Compare EDIT & LOGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- LOGC
- Stock Information
- Founded
- EDIT 2013
- LOGC 2010
- Country
- EDIT United States
- LOGC United States
- Employees
- EDIT N/A
- LOGC N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- LOGC Catalog/Specialty Distribution
- Sector
- EDIT Health Care
- LOGC Consumer Discretionary
- Exchange
- EDIT Nasdaq
- LOGC Nasdaq
- Market Cap
- EDIT 176.7M
- LOGC 186.6M
- IPO Year
- EDIT 2016
- LOGC 2020
- Fundamental
- Price
- EDIT $1.32
- LOGC $6.74
- Analyst Decision
- EDIT Buy
- LOGC
- Analyst Count
- EDIT 14
- LOGC 0
- Target Price
- EDIT $8.08
- LOGC N/A
- AVG Volume (30 Days)
- EDIT 3.3M
- LOGC 266.9K
- Earning Date
- EDIT 11-04-2024
- LOGC 11-07-2024
- Dividend Yield
- EDIT N/A
- LOGC N/A
- EPS Growth
- EDIT N/A
- LOGC N/A
- EPS
- EDIT N/A
- LOGC N/A
- Revenue
- EDIT $61,759,000.00
- LOGC $96,000,000.00
- Revenue This Year
- EDIT N/A
- LOGC N/A
- Revenue Next Year
- EDIT N/A
- LOGC $422.91
- P/E Ratio
- EDIT N/A
- LOGC N/A
- Revenue Growth
- EDIT 150.95
- LOGC N/A
- 52 Week Low
- EDIT $1.28
- LOGC $4.01
- 52 Week High
- EDIT $11.58
- LOGC $8.24
- Technical
- Relative Strength Index (RSI)
- EDIT 24.88
- LOGC 40.45
- Support Level
- EDIT $1.28
- LOGC $7.03
- Resistance Level
- EDIT $2.37
- LOGC $8.21
- Average True Range (ATR)
- EDIT 0.18
- LOGC 0.37
- MACD
- EDIT -0.04
- LOGC -0.16
- Stochastic Oscillator
- EDIT 6.45
- LOGC 12.98
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About LOGC ContextLogic Inc.
ContextLogic Inc is an online shopping store. The store provides personalized products, clothing products, accessories, gaming products and equipment, cosmetics, plastic products, mobile covers, and other products. Geographically, it derives a majority of its revenue from Europe and also has a presence in North America; South America, and other countries.